Patient selection flowchart.

<p>Patient selection flowchart.</p

The influence of comorbidity according to CCI, ACCI and HN-CCI on patient survival.

<p>The influence of comorbidity according to CCI, ACCI and HN-CCI on patient survival.</p

Receiver operating characteristic curve compared the discriminating ability for predicting survival of the ACCI (area = 0.693; 95% CI 0.670 to 0.715), CCI (area = 0.619; 95% CI 0.593 to 0.644) and HN-CCI (area = 0.545; 95% CI 0.519 to 0.570).

<p>Receiver operating characteristic curve compared the discriminating ability for predicting survival of the ACCI (area = 0.693; 95% CI 0.670 to 0.715), CCI (area = 0.619; 95% CI 0.593 to 0.644) and HN-CCI (area = 0.545; 95% CI 0.519 to 0.570).</p

Comorbidity Distribution Based on the HN-CCI (n = 4095).

<p>Comorbidity Distribution Based on the HN-CCI (n = 4095).</p

Patient Characteristics.

<p>Abbreviations: nasopharyngeal carcinoma, NPC;+CT, chemotherapy; ‡RT, Radiation therapy; SD, standard deviation; CCI, Charlson Comorbidity Index; ACCI, Age-Adjusted Charlson Comorbidity Index; HN-CCI, revised head and neck Charlson Comorbidity Index</p><p>Demographic characteristics for NPC patients from 2007 to 2011 (n = 4095).</p><p>Patient Characteristics.</p

Comorbidity Distribution Based on the Charlson Comorbidity Index (n = 4095).

<p>Comorbidity Distribution Based on the Charlson Comorbidity Index (n = 4095).</p

sj-docx-2-onc-10.1177_11795549221113244 – Supplemental material for Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma

Supplemental material, sj-docx-2-onc-10.1177_11795549221113244 for Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma by Sung-Wei Lee, Ching-Chieh Yang, Hong-Yue Lai, Hsin-Hwa Tsai, Cheng-Fa Yeh, Yu-Hsuan Kuo, Nai-Wen Kang, Tzu-Ju Chen and Shih-Lun Chang in Clinical Medicine Insights: Oncology</p

sj-docx-3-onc-10.1177_11795549221113244 – Supplemental material for Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma

Supplemental material, sj-docx-3-onc-10.1177_11795549221113244 for Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma by Sung-Wei Lee, Ching-Chieh Yang, Hong-Yue Lai, Hsin-Hwa Tsai, Cheng-Fa Yeh, Yu-Hsuan Kuo, Nai-Wen Kang, Tzu-Ju Chen and Shih-Lun Chang in Clinical Medicine Insights: Oncology</p

sj-docx-1-onc-10.1177_11795549221113244 – Supplemental material for Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma

Supplemental material, sj-docx-1-onc-10.1177_11795549221113244 for Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma by Sung-Wei Lee, Ching-Chieh Yang, Hong-Yue Lai, Hsin-Hwa Tsai, Cheng-Fa Yeh, Yu-Hsuan Kuo, Nai-Wen Kang, Tzu-Ju Chen and Shih-Lun Chang in Clinical Medicine Insights: Oncology</p